Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00804206
NCT00804206
Terminated
Phase 4

Phase 4 Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Asociación para Evitar la Ceguera en México1 site in 1 country15 target enrollmentJuly 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMacular Edema
Interventionsbevacizumab
Drugsbevacizumab

Overview

Phase
Phase 4
Intervention
bevacizumab
Conditions
Macular Edema
Sponsor
Asociación para Evitar la Ceguera en México
Enrollment
15
Locations
1
Primary Endpoint
Central macular thickness
Status
Terminated
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

Compare the effect of an intravitreal injection of bevacizumab previous or posterior of panretinal laser photocoagulation (PRLP) with a pattern laser; to prevent and reduce diabetic macular edema (DME) in patients with proliferative diabetic retinopathy (PDR) with DME.

Registry
clinicaltrials.gov
Start Date
July 2008
End Date
July 2008
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Asociación para Evitar la Ceguera en México
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Patients with proliferative diabetic retinopathy
  • •patients with macular edema

Exclusion Criteria

  • •patients with previous treatments
  • •patients with ocular surgeries

Arms & Interventions

Group A

Bevacizumab before panretinal photocoagulation.

Intervention: bevacizumab

Group B

Bevacizumab after panretinal photocoagulation

Intervention: bevacizumab

Outcomes

Primary Outcomes

Central macular thickness

Time Frame: baseline, 10 days, 52 days, 85 days

Secondary Outcomes

  • Best corrected visual acuity(baseline, 10 days, 52 days, 85 days)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 4
Effect of the Adjunctive IVB Before PRPDiabetic Retinopathy
NCT01504724Kyungpook National University Hospital30
Unknown
Phase 2
Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous HemorrhageVitreous Hemorrhage Secondary to PDR
NCT01091896University of Sao Paulo1
Unknown
Phase 3
Bevacizumab Versus Ranibizumab in Age Related Macular DegenerationAge Related Macular Degeneration
NCT01014468Instituto de Olhos de Goiania500
Terminated
Phase 2
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular DegenerationAge Related Macular Degeneration
NCT00347399Asociación para Evitar la Ceguera en México25
Unknown
Phase 2
Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical TrialAge Related Macular Degeneration
NCT03609307Shahid Beheshti University of Medical Sciences40